Xtant Medical Holdings, Inc.

XTNT Healthcare Medical Devices

Xtant Medical Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $133.9 million, up 14.2% from fiscal 2024. In the quarter to June 2026, revenue fell 35.0%, EPS fell 333.3%, free cash flow fell 882.0% and total debt fell 33.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

0.28 0.02 −6.67%
Market cap
$42.5M
P/E
0.0×
Fwd P/E
−9.1×
Dividend yield
—
F-score
8/9
Altman Z
0.03
Beneish M
−3.11
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

31.86 19.12 27.45 0.00
P/S ratio
0.68 0.81 0.64 0.54
P/FCF ratio
16.56 10.47 9.81 0.00
P/Operating CF
19.69 20.23 (37.10) (8.06)
P/B ratio
1.80 2.14 1.61 1.47
EV/Sales
0.82 0.87 0.64 0.65
EV/EBITDA
9.99 9.35 9.84 0.00
EV/FCF
19.86 11.24 9.82 (156.17)
Current Ratio
2.21 2.65 3.34 2.16
Net Debt/EBITDA
4.89 9.22 (0.04) (1.47)
Debt/Equity
0.57 0.50 0.25 0.57
Earnings Yield
3.14% 5.23% 3.64% (18.95%)
Free Cash Flow Yield
6.04% 9.55% 10.20% (0.78%)
Free Cash Flow per Share
0.03 0.04 (0.02) (0.05)
Book value per Share
0.36 0.37 0.35 0.29
Free Cash Flow
4.29 5.01 (2.26) (7.50)
EV/EBIT
17.16 16.05 23.81 0.00
Other line items

Show all line items

Columns are period end dates